Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
The Rotterdam Prostate Cancer Risk Calculator (RPCRC) is a well-validated tool for upfront risk stratification to reduce the number of prostate biopsies and magnetic resonance imaging scans among both biopsy-naïve and previously biopsied men. The presence of invasive cribriform and/or intraductal ca...
Main Authors: | Sebastiaan Remmers, Daan Nieboer, L. Lucia Rijstenberg, Tim Hansum, Geert J.L.H. van Leenders, Monique J. Roobol |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-02-01
|
Series: | European Urology Open Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168321033863 |
Similar Items
-
Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
by: Sebastiaan Remmers, et al.
Published: (2022-02-01) -
The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
by: Sebastiaan Remmers, et al.
Published: (2023-05-01) -
Prostate cancer screening in the elderly: A yes or no issue? Long term follow-up data from ERSPC Rotterdam
by: M.J. Roobol, et al.
Published: (2020-07-01) -
Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology
by: Ei Shiomi, et al.
Published: (2023-05-01) -
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
by: Daniël F. Osses, et al.
Published: (2020-12-01)